Bone cancer and sarcoma treatment in India
Sarcomas are uncommon cancers of bone and soft tissue, and they are the clearest example on this site of a disease where being treated by a specialist team from the very first step changes the outcome. That first step is the biopsy, and getting it wrong can cost a limb.
- Two families
- Bone sarcoma such as osteosarcoma and Ewing; and soft tissue sarcoma
- Who it affects
- Osteosarcoma and Ewing sarcoma often in teenagers and young adults
- Limb salvage
- Now possible in the large majority of cases, rather than amputation
- Usual sequence
- Chemotherapy first, then surgery, then more chemotherapy
- Critical
- The biopsy must be planned by the team that will operate
- First step
- A sarcoma specialist reviews your imaging and pathology on video, free
Why the biopsy comes first on this page
A badly placed biopsy can turn a limb-saving operation into an amputation. The needle track contaminates tissue with tumour cells and has to be removed with the tumour at surgery. If it has been placed through the wrong compartment, across structures the surgeon needed to preserve, or through a route that cannot be excised, options narrow permanently. This is not a theoretical risk; it is one of the best documented problems in sarcoma care.
The consequence is simple and worth acting on: if a bone or soft tissue tumour is suspected, the biopsy should be planned by, and ideally performed at, the centre that would carry out the definitive surgery. If you have imaging suggesting a sarcoma and nobody has taken a sample yet, send the images before that happens.
The two families
Bone sarcomas. Osteosarcoma is the commonest, typically affecting teenagers and young adults, most often around the knee, and usually presenting as deep, persistent bone pain, frequently worse at night, sometimes with swelling. Ewing sarcoma also affects young people and can involve the pelvis and other bones, sometimes with fever that leads to it being mistaken for infection. Chondrosarcoma affects older adults and responds differently to treatment.
Soft tissue sarcomas. Arise in muscle, fat, nerve or connective tissue anywhere in the body, and are usually noticed as a painless lump that keeps growing. Any soft tissue lump that is larger than a golf ball, lies deep to the muscle layer, or is growing should be imaged before anyone attempts to remove it as a lipoma.
Persistent deep bone pain in a teenager, particularly pain that wakes them at night, deserves an X-ray rather than reassurance about growing pains or a sports injury. This is the single most common route to a delayed osteosarcoma diagnosis.
Limb salvage instead of amputation
This is the part of sarcoma treatment that has changed most, and people arriving with a diagnosis often do not know it.
In the large majority of bone sarcomas of the limbs, the tumour can now be removed and the bone reconstructed, rather than the limb amputated. Reconstruction may use a custom metal endoprosthesis, a bone graft, or in growing children an expandable implant that can be lengthened as they grow.
Amputation is still the right answer in some situations: where the tumour involves the main nerves and blood vessels, where infection or fracture has complicated things, or where a reconstructed limb would be less functional than a prosthesis. A surgeon who explains honestly why amputation is being recommended, rather than treating it as a failure, is giving you good information.
If amputation has been recommended and you have not had a second opinion from a sarcoma unit, that is worth seeking. Not because the recommendation is necessarily wrong, but because it is a decision you live with permanently and it deserves two views.
Chemotherapy before and after
For osteosarcoma and Ewing sarcoma, the standard sequence is chemotherapy first, then surgery, then more chemotherapy. Treating before surgery shrinks the tumour, treats microscopic spread, and, importantly, allows the pathologist to see how much of the tumour was killed by the drugs, which is one of the strongest indicators of how the disease is likely to behave.
Most soft tissue sarcomas are treated primarily with surgery, often with radiotherapy before or after to reduce local recurrence, and chemotherapy has a more selective role depending on the subtype.
Sarcoma chemotherapy is intensive, and for young patients its effect on future fertility is a real issue that should be discussed before treatment starts, not after. Sperm banking, and egg or ovarian tissue preservation, need arranging first. Ask about it explicitly; it is frequently missed in the urgency of starting treatment.
The subtype matters enormously
Sarcoma is not one disease. There are dozens of subtypes and they behave very differently, respond to different drugs, and carry different outlooks. A general pathology report saying simply "sarcoma" is not enough to plan treatment.
Specialist sarcoma pathology review, sometimes including molecular testing, changes the diagnosis in a meaningful proportion of cases referred from non-specialist centres. If your report is non-specific, ask for the slides to be reviewed by a sarcoma pathologist before treatment is decided.
What we can say about the shape of it: sarcoma treatment is long, typically several months of chemotherapy either side of surgery, so plan for an extended stay rather than a single procedure. Custom endoprostheses for limb reconstruction are made to measure and are a substantial part of the cost. Ask for the chemotherapy, the surgery and any implant to be itemised separately in your estimate.
Questions patients ask
Can bone cancer be cured?
Many bone sarcomas are treated with curative intent, particularly osteosarcoma and Ewing sarcoma in young people who have not developed spread, using chemotherapy before and after surgery. Outcomes depend heavily on the subtype, whether it has spread, and how well the tumour responds to the initial chemotherapy. A specialist reviewing your case can give a realistic picture.
Will I lose my limb?
In the large majority of limb bone sarcomas, no. Limb salvage with removal of the tumour and reconstruction using a custom implant or bone graft has largely replaced amputation. Amputation remains right in some situations, such as when the main nerves and vessels are involved. If it has been recommended, a second opinion from a sarcoma unit is worth having.
Why does the biopsy matter so much?
Because a badly placed biopsy track contaminates tissue with tumour cells and must be removed along with the tumour at surgery. If it crosses the wrong compartment or structures the surgeon needed to preserve, limb salvage can become impossible. The biopsy should be planned by the team that would perform the definitive surgery.
My teenager has bone pain at night. Should I be worried?
It deserves an X-ray rather than reassurance about growing pains or a sports injury. Deep, persistent bone pain that wakes a young person at night, particularly around the knee, is the classic presentation of osteosarcoma, and dismissing it is the most common route to a delayed diagnosis. Most such pain turns out to be benign, which is exactly why the X-ray is quick and worth doing.
I have a lump in my thigh. Does it need investigating?
If it is larger than a golf ball, lies deep to the muscle layer, or is growing, it should be imaged before anyone attempts to remove it as a simple lipoma. Soft tissue sarcomas commonly present as a painless growing lump, and an unplanned excision by someone who assumed it was benign complicates the definitive surgery considerably.
How long does sarcoma treatment take?
Longer than most treatments on this site. The usual sequence is several months of chemotherapy, then surgery, then further chemotherapy, so plan for an extended stay rather than a single procedure. Your team will give a specific timeline once the subtype and stage are established.
Will treatment affect fertility?
Sarcoma chemotherapy is intensive and can affect future fertility, which matters particularly because many patients are teenagers and young adults. Sperm banking, and egg or ovarian tissue preservation, need arranging before treatment starts. Ask about it explicitly, because it is frequently missed in the urgency of beginning treatment.
My report just says sarcoma. Is that enough to plan treatment?
No. There are dozens of subtypes that behave very differently and respond to different drugs. Specialist sarcoma pathology review, sometimes with molecular testing, changes the diagnosis in a meaningful proportion of cases referred from non-specialist centres. Ask for the slides to be reviewed before treatment is decided.